---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-25-006811"
form_type: "8-K"
ticker: "NDRA"
cik: "0001681682"
company_name: "ENDRA Life Sciences Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T13:25:52.918936+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.05
calibrated_materiality_score: 0.05
confidence: "low"
source: SEC EDGAR
---

# ENDRA posts updated investor presentation reflecting new business strategy announced March 31, 2025

## Summary
- Filed under Item 7.01; presentation posted on company website without new financial or operational data.
- No new material facts disclosed; presentation references previously announced strategy shift.
- Filing contains only procedural language; investor gains no actionable information from this 8-K alone.

## SEC filing metadata
- accession: 0001654954-25-006811
- form_type: 8-K
- ticker: NDRA
- cik: 0001681682
- company_name: ENDRA Life Sciences Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.05
- calibrated_materiality_score: 0.05
- confidence: low
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1681682/000165495425006811/0001654954-25-006811-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1681682/000165495425006811/endra_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-25-006811
- JSON: https://secwatch.observer/filing/0001654954-25-006811.json
- Plain text: https://secwatch.observer/filing/0001654954-25-006811.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.